Viewing Study NCT05973968


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2025-12-30 @ 8:44 AM
Study NCT ID: NCT05973968
Status: UNKNOWN
Last Update Posted: 2023-08-04
First Post: 2023-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Surufatinib in G3 Neuroendocrine Tumors
Sponsor: Qilu Hospital of Shandong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module